Evidence map›Paper›PMID 29844397›Full record

ArticleCell death & disease2018

The cyclohexene derivative MC-3129 exhibits antileukemic activity via RhoA/ROCK1/PTEN/PI3K/Akt pathway-mediated mitochondrial translocation of cofilin.

Yi Zheng, Qin Ouyang, Ruoqiu Fu, Lei Liu, Hongwei Zhang, Xiaoye Hu, Yanxia Liu, Yingchun Chen, Ning Gao

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. MiR-361-5p/International journal of chronic obstructive pulmonary disease
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yi ZhengCollege of Pharmacy, Third Military Medical University, 400038, Chongqing, China.
Qin OuyangCollege of Pharmacy, Third Military Medical University, 400038, Chongqing, China.
Ruoqiu FuCollege of Pharmacy, Third Military Medical University, 400038, Chongqing, China.
Lei LiuCollege of Pharmacy, Third Military Medical University, 400038, Chongqing, China.
Hongwei ZhangCollege of Pharmacy, Third Military Medical University, 400038, Chongqing, China.
Xiaoye Hu
Yanxia LiuCollege of Pharmacy, Third Military Medical University, 400038, Chongqing, China.
Yingchun ChenCollege of Pharmacy, Third Military Medical University, 400038, Chongqing, China. ycchen@scu.edu.cn.
Ning GaoCollege of Pharmacy, Third Military Medical University, 400038, Chongqing, China. gaoning59@163.com.
Army Medical University · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 81402013National Natural Science Foundation of China (National Science Foundation of China) 81402202
6 · The paper itself

Abstract

The effects of MC-3129, a synthetic cyclohexene derivative, on cell viability and apoptosis have been investigated in human leukemia cells. Exposure of leukemia cells to MC-3129 led to the inhibition of cell viability and induction of apoptosis through the dephosphorylation and mitochondrial translocation of cofilin. A mechanistic study revealed that interruption of the RhoA/ROCK1/PTEN/PI3K/Akt signaling pathway plays a crucial role in the MC-3129-mediated dephosphorylation and mitochondrial translocation of cofilin and induction of apoptosis. Our in vivo study also showed that the MC-3129-mediated inhibition of the tumor growth in a mouse leukemia xenograft model is associated with the interruption of ROCK1/PTEN/PI3K/Akt signaling and apoptosis. Molecular docking suggested that MC-3129 might activate the RhoA/ROCK1 pathway by targeting LPAR2. Collectively, these findings suggest a hierarchical model, in which the induction of apoptosis by MC-3129 primarily results from the activation of RhoA/ROCK1/PTEN and inactivation of PI3K/Akt, leading to the dephosphorylation and mitochondrial translocation of cofilin, and culminating in cytochrome c release, caspase activation, and apoptosis. Our study reveals a novel role for RhoA/ROCK1/PTEN/PI3K/Akt signaling in the regulation of mitochondrial translocation of cofilin and apoptosis and suggests MC-3129 as a potential drug for the treatment of human leukemia.

Indexed as

Actin Depolymerizing FactorsAnimalsAntineoplastic AgentsApoptosisbcl-2-Associated X Proteinbcl-Associated Death ProteinCell Line, TumorCell ProliferationCell SurvivalCyclohexenesDown-RegulationHumansLeukemiaMiceMitochondriaMolecular Docking SimulationActin Depolymerizing FactorsAntineoplastic Agentsbcl-2-Associated X Proteinbcl-Associated Death ProteinCyclohexenesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePTEN protein, humanrhoA GTP-Binding Proteinrho-Associated KinasesROCK1 protein, human

Identifiers

PMID29844397
PMCPMC5974298
OpenAlexW2805603491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.